Online citations, reference lists, and bibliographies.

Reevaluation Of Postoperative Radiation Dose In The Management Of Human Papillomavirus-positive Oropharyngeal Cancer.

Re-I Chin, Christopher R. Spencer, Todd A DeWees, Michael Y. Hwang, Pranav V. Patel, Parul Khare Sinha, Hiram A. Gay, Bruce H. Haughey, Brian Nussenbaum, Douglas R. Adkins, James S. Lewis, W. L. Thorstad
Published 2016 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
BACKGROUND The purpose of this study was to compare outcomes of patients with p16-positive oropharyngeal squamous cell carcinoma (SCC) treated with postoperative intensity-modulated radiotherapy (IMRT) before and after an institutional dose reduction policy effective on February 2009. METHODS Between 1998 and 2013, 175 consecutive patients with p16-positive oropharyngeal SCC with extracapsular extension (ECE) and/or close or positive margins were treated postoperatively to 66 Gy (n = 109) or 60 Gy (n = 66) in 2 Gy/fx. RESULTS Between the 66 and 60 Gy groups, there was no difference in tumor classification (pT4 vs pT1-T3; p = .181) and nodal classification (pN2c-N3 vs pN0-N2b; p = .704), and American Joint Committee on Cancer (AJCC) group stage (IV vs I-III; p = .473). Median follow-up was 5.9 years overall (66 Gy: 7.4 years; 60 Gy: 4.0 years). There was no difference in locoregional recurrence-free survival (2-year: 98.1% vs 98.5%; p = .421). CONCLUSION This study suggests that treating p16-positive oropharyngeal SCC with ECE and/or close or positive margins with postoperative IMRT to 60 Gy may not compromise locoregional recurrence-free survival compared to 66 Gy. © 2016 Wiley Periodicals, Inc. Head Neck 38: 1708-1716, 2016.
This paper references
Transoral laser microsurgery as primary treatment for advanced-stage oropharyngeal cancer: a United States multicenter study.
Bruce H. Haughey (2011)
Swallowing function after transoral laser microsurgery (TLM) ± adjuvant therapy for advanced-stage oropharyngeal cancer.
Jason T. Rich (2011)
Do practice guidelines guide practice? The effect of a consensus statement on the practice of physicians.
Jonathan Lomas (1989)
Enhanced radiation sensitivity in HPV-positive head and neck cancer.
Randall J. Kimple (2013)
Eliminating radiotherapy to the contralateral retropharyngeal and high level II lymph nodes in head and neck squamous cell carcinoma is safe and improves quality of life.
Christopher R. Spencer (2014)
Extracapsular extension is a poor predictor of disease recurrence in surgically treated oropharyngeal squamous cell carcinoma
James S. Lewis (2011)
Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy.
Johannes A. Langendijk (2008)
Prevalence of heavy smoking in California and the United States, 1965-2007.
John P Pierce (2011)
From evidence to practice in the United States, the United Kingdom, and Canada.
Jonathan Lomas (1993)
Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: Clinical and functional results
Felix Yi-Chung Feng (2011)
Nodal status is not a prognostic factor in patients with HPV-positive oral/oropharyngeal tumors.
Jan Klozar (2013)
De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinoma: a systematic review and meta-analysis of current clinical trials.
Liam Masterson (2014)
Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
Bruce H. Haughey (2012)
Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.
Jacques Bernier (2004)
Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma.
Wei Shi (2009)
Randomized study of preoperative versus postoperative radiation therapy in advanced head and neck carcinoma: long-term follow-up of RTOG study 73-03.
Leslie Tupchong (1991)
In vitro 3-dimensional tumor model for radiosensitivity of HPV positive OSCC cell lines
Mei Zhang (2015)
Extracapsular spread in head and neck carcinoma: impact of site and human papillomavirus status.
Jessica H. Maxwell (2013)
Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial.
Lester J. Peters (1993)
Projections of Global Mortality and Burden of Disease from 2002 to 2030
Colin Douglas Mathers (2006)
Margin mapping in transoral surgery for head and neck cancer.
Michael L. Hinni (2013)
Extracapsular spread and adjuvant therapy in human papillomavirus-related, p16-positive oropharyngeal carcinoma.
Parul Khare Sinha (2012)
Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer.
Maura L. Gillison (2012)
Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer.
K Kian Ang (2001)
Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck.
Jay Scott Cooper (2004)
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
James A. Stockman (2012)
Outcomes of HPV-related oropharyngeal cancer patients treated by radiotherapy alone using altered fractionation.
B O'Sullivan (2012)

This paper is referenced by
Absolute Clinical Radiation Oncology Review
Daniel M. Trifiletti (2019)
Does elimination of planned postoperative radiation to the primary bed in p16-positive, transorally-resected oropharyngeal carcinoma associate with poorer outcomes?
Parul Khare Sinha (2016)
Multi-institutional analysis of outcomes following transoral surgery for HPV-positive oropharyngeal squamous cell carcinoma in elderly patients.
Ryan S Jackson (2019)
Pretreatment metabolic tumor volume as a prognostic factor in HPV‐associated oropharyngeal cancer in the context of AJCC 8th edition staging
John M Floberg (2018)
Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck – clinical results from the cohort of the clinical cooperation group “Personalized Radiotherapy in Head and Neck Cancer”
Cornelius Maihoefer (2018)
Long-term analysis of transorally resected p16 + Oropharynx cancer: Outcomes and prognostic factors.
Parul Khare Sinha (2019)
Survival for HPV-positive oropharyngeal squamous cell carcinoma with surgical versus non-surgical treatment approach: A systematic review and meta-analysis.
Parul Khare Sinha (2018)
Head and Neck Cancers
Daniel M. Trifiletti (2016)
Long-term Functional and Quality-of-Life Outcomes After Transoral Robotic Surgery in Patients With Oropharyngeal Cancer
Virginie Achim (2017)
De-intensification of adjuvant therapy in human papillomavirus-associated oropharyngeal cancer
Yi An (2016)
Management of the Neck for Oropharyngeal Squamous Cell Carcinoma in the Era of Transoral Robotic-Assisted Surgery (TORS)
Rajarsi Mandal (2017)
Postoperative radiotherapy dose requirement in standard combined‐modality practice for head and neck squamous cell carcinoma: Analysis of salient surgical and radiotherapy parameters in 2 cohorts
Bidhu K Mohanti (2017)
Semantic Scholar Logo Some data provided by SemanticScholar